Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer

Ann H. Partridge, Samuel M. Niman, Monica Ruggeri, +36

New England Journal of Medicine

Activation of PI3K/Akt signaling and hormone resistance in breast cancer

Eriko Tokunaga, Yasue Kimura, Kojiro Mashino, +7

Breast Cancer

Tumor BiologyBreast OncologySignal TransductionSignaling PathwayMedicine +8

The association between Akt activation and resistance to hormone therapy in metastatic breast cancer

Eriko Tokunaga, Akemi Kataoka, Yasue Kimura, +9

European Journal of Cancer

Metastatic Breast CancerOncologyBreast OncologyMedicineHormonal Receptor +7

Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry

Akemi Kataoka, Takayuki Iwamoto, Eriko Tokunaga, +16

Breast Cancer Research and Treatment

Prognostic and predictive value of epidermal growth factor receptor in recurrent breast cancer.

Shinichi Tsutsui, Akemi Kataoka, Shinji Ohno, +3

PubMed

Unmet Information Needs and Quality of Life in Young Breast Cancer Survivors in Japan

Mika Miyashita, Shinji Ohno, Akemi Kataoka, +5

Cancer Nursing

Correlated Expression of<i>CD47</i>and<i>SIRPA</i>in Bone Marrow and in Peripheral Blood Predicts Recurrence in Breast Cancer Patients

Makoto Nagahara, Koshi Mimori, Akemi Kataoka, +7

Clinical Cancer Research

Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy

Ann H. Partridge, Samuel M. Niman, Monica Ruggeri, +29

The Breast

Prognostic value of the combination of epidermal growth factor receptor and c-erbB-2 in breast cancer

Shinichi Tsutsui, Shinji Ohno, Shigeru Murakami, +3

Surgery

Breast OncologyMedicinePrognostic ValueCancer GrowthPathology +6

The clinical significance of MMP-1 expression in oesophageal carcinoma

Keishi Yamashita, Masaki Mori, Akemi Kataoka, +2

British Journal of Cancer

Tumoral PathologyEsophageal CancerPutative Active Mmp-1MedicineMmp-1 Mrna +12